What does Bio-Techne Corp. do?

Jun 22 2025 06:02 PM IST
share
Share Via
Bio-Techne Corporation develops and sells biotechnology reagents and instruments for research and clinical diagnostics, with recent net sales of $316 million and a market cap of approximately $7.76 billion. Key financial metrics include a P/E ratio of 37.00 and a dividend yield of 64.92%.
Overview:
Bio-Techne Corporation develops, manufactures, and sells biotechnology reagents and instruments for the research and clinical diagnostic markets, operating in the Pharmaceuticals & Biotechnology industry within the mid-cap market segment.

Financial Snapshot:
Most recent Net Sales: 316 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: 23 Million (Quarterly Results - Mar 2025)
Market-cap: USD 7,759.98 Million (Mid Cap)

Key Metrics:
P/E: 37.00
Dividend Yield: 64.92%
Debt Equity: 0.10
Return on Equity: 10.25%
Price to Book: 3.85

Contact Details:
Address: 614 McKinley Pl NE, MINNEAPOLIS MN: 55413-2610
Tel: ['1 612 3798854', '1 646 2771266']
Fax: 1 612 6564400
Website: https://www.bio-techne.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News